Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

84
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.7K
The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding and addressing the obstacles to a trial of face masks in schools: a mixed-methods feasibility study.

Pilot and feasibility studies·2026
Same author

Non-antimicrobial interventions in recovery from community-acquired pneumonia in adults.

Current opinion in infectious diseases·2026
Same author

Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type.

Wellcome open research·2026
Same author

Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control study.

The Lancet. Infectious diseases·2025
Same author

Burden of respiratory syncytial virus infection in older adults hospitalised in England during 2023/24.

The Journal of infection·2025
Same author

Lessons from the PROTECT-CH COVID-19 platform trial in care homes.

Health technology assessment (Winchester, England)·2025

Related Experiment Video

Updated: May 1, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

48.4K

The relevance of pneumococcal serotypes.

Chamira Rodrigo1, Wei Shen Lim

  • 1Department of Respiratory Medicine, City Campus, Nottingham University Hospitals NHS Trust, Nottingham, NG51PB, UK, chamira@doctors.org.uk.

Current Infectious Disease Reports
|March 25, 2014
PubMed
Summary

Pneumococcal disease poses a global health threat, with varying severity and antibiotic resistance among its many serotypes. Understanding these serotype-specific differences is crucial for effective prevention and treatment strategies.

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

23.7K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K

Related Experiment Videos

Last Updated: May 1, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

48.4K
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

23.7K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K

Area of Science:

  • Medical Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Pneumococcal disease causes significant global mortality, morbidity, and healthcare costs.
  • Disease rates are expected to rise due to an aging population.
  • Over 90 pneumococcal serotypes exist, each inducing serotype-specific immunity.

Purpose of the Study:

  • To highlight the importance of serotype-specific characteristics in pneumococcal disease.
  • To inform current and future treatment and prevention strategies.
  • To address seroepidemiological changes influenced by vaccination.

Main Methods:

  • Review of recent studies on pneumococcal serotypes.
  • Analysis of serotype-specific differences in invasiveness and disease severity.
  • Surveillance of serotypes in nasopharyngeal carriage and disease.

Main Results:

  • Significant variations exist among pneumococcal serotypes regarding invasiveness, disease severity, and complications.
  • Antibiotic resistance patterns are serotype-specific.
  • Introduction of pneumococcal conjugate vaccination impacts seroepidemiology.

Conclusions:

  • Characterizing pneumococcal serotype-specific clinical features is essential.
  • Continued surveillance of serotypes is vital for guiding public health interventions.
  • Tailored strategies are needed to combat the diverse threat of pneumococcal disease.